High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.
Nijmegen breakage syndrome (NBS), a rare autosomal recessive chromosomal instability disorder, is caused by mutations in the NBN gene. Most patients known so far are of Slavic origin and carry the major founder mutation c.657-661del5. Due to an unexpectedly high incidence of NBS patients (homozygous for the c.657-661del5 mutation) in a Northeast Bavarian region in Southeast Germany, we estimated the prevalence of this mutation in this area and compared it to another German region. We found a high carrier frequency of 1/176 for the c.657-661del5 mutation among newborns in Northeast Bavaria, while the frequency of the mutation in Berlin was 1/990. We further studied families from a Slavic population isolate, the Sorbs, in the Lusatian region in Northeast Saxony, and revealed a prevalence of the c.657-661del5 mutation of 1/34. Whereas the Slavic origin of the Sorbs has been known, we attribute the surprisingly high frequencies of c.657-661del5 mutation in Bavaria (similar to frequencies of this mutation in various Eastern European countries) to a high percentage of people of Slavic origin in Northeast Bavaria.
Maurer
M H
MH
Institute of Human Genetics, Charité University Hospital, Berlin, Germany. martin.maurer@charite.de
Hoffmann
K
K
Sperling
K
K
Varon
R
R
D018797:Cell Cycle Proteins / Q000235:genetics*; D043171:Chromosomal Instability / Q000235:genetics; D018703:Founder Effect; D005787:Gene Frequency; D005843:Geography; D005858:Germany; D006720:Homozygote; D008223:Lymphoma / Q000453:epidemiology / Q000235:genetics; D009154:Mutation; D009369:Neoplasms / Q000453:epidemiology / Q000235:genetics; D049932:Nijmegen Breakage Syndrome / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D017384:Sequence Deletion
D018797:Cell Cycle Proteins; C112156:NBN protein, human; D009687:Nuclear Proteins
Cancer Res. 2003 Oct 1;63(19):6563-4; author reply 6565
14559852
Mutat Res. 1990 May;238(3):321-4
2342514
J Appl Genet. 2008;49(4):383-96
19029686
Melanoma Res. 2003 Aug;13(4):365-70
12883362
Int J Cancer. 2005 Apr 20;114(4):585-9
15578693
Int J Cancer. 2008 Feb 15;122(4):802-6
17957789
Radiother Oncol. 2006 Dec;81(3):257-63
17113667
Radiat Res. 2002 Sep;158(3):319-26
12175309
Int J Cancer. 2004 Aug 10;111(1):67-71
15185344
Cancer Res. 2001 May 1;61(9):3570-2
11325820
Arch Dis Child. 2000 May;82(5):400-6
10799436
Cancer Genet Cytogenet. 2002 Oct 15;138(2):157-9
12505263
Nat Genet. 1998 Jun;19(2):179-81
9620777
Cell. 1998 May 1;93(3):467-76
9590180
Pediatr Blood Cancer. 2009 Feb;52(2):186-90
18937313
Cancer Res. 2004 Feb 15;64(4):1215-9
14973119
Int J Cancer. 2003 Sep 1;106(3):379-81
12845677
Cell. 1998 May 1;93(3):477-86
9590181
J Natl Cancer Inst. 2007 Dec 19;99(24):1875-80
18073374
Nat Cell Biol. 2005 Jul;7(7):675-85
15965469
Am J Med Genet. 1995 Jul 3;57(3):462-71
7545870
Eur J Cancer. 2008 Mar;44(4):627-30
18280732
Genes Chromosomes Cancer. 1999 Aug;25(4):393-5
10398434
Radiat Res. 2002 Mar;157(3):312-21
11839094
Ann Oncol. 2000;11 Suppl 1:141-5
10707797